Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
Resources for Press
01
All the Right Ingredients: A Q&A with the Founders of ArsenalBio
02
NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer
03
Five Key Takeaways from the 2021 ASCO Annual Meeting
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Transformative science requires visionary philanthropy
Join us. Change lives.
We combined forces with the brightest minds in the field to radically change the way research is done – to save lives faster.
Our model is designed to remove barriers, encourage collaboration and turn ideas into real-world cancer treatments.
80+
Research collaborators
142
Pici-Supported research Projects
Clinical trials in progress
275+
Patients treated
Industry and nonprofit collaborations
6
strategic investments
One-on-one data collaborations across 7 sites
17
Molecular data types analyzed
invention disclosures Reviewed
122
Inventions supported
Biospecimens collected
18
Translational suite assays